Related references
Note: Only part of the references are listed.Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
Jinhua Li et al.
DIABETES (2010)
Latent TGF-β-binding protein 4 modifies muscular dystrophy in mice
Ahlke Heydemann et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Smad7 as a therapeutic agent for chronic kidney diseases
Hui Yao Lan
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Smad ubiquitination regulatory factor-2 in the fibrotic kidney: regulation, target specificity, and functional implication
Ruoyun Tan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Regulation of collagen synthesis by inhibitory Smad7 in cardiac myofibroblasts
Baiqiu Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice
Shuk-Man Ka et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
TGF-β in renal injury and disease
Erwin P. Bottinger
SEMINARS IN NEPHROLOGY (2007)
Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-β1-induced extracellular matrix expression
M Jinnin et al.
MOLECULAR PHARMACOLOGY (2006)
Signaling mechanism of TGF-βl in prevention of renal inflammation:: Role of Smad7
WS Wang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Smad3 as a mediator of the fibrotic response
KC Flanders
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2004)
Smad-dependent and Smad-independent pathways in TGF-β family signalling
R Derynck et al.
NATURE (2003)
Latency-associated peptide prevents skin fibrosis in murine sclerodermatous graft-versus-host disease, a model for human scleroderma
Y Zhang et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
Smad3 mediates transforming growth factor-β-induced α-smooth muscle actin expression
B Hu et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Sustained activation of fibroblast transforming growth Factor-β/Smad signaling in a murine model of scleroderma
S Takagawa et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2003)
The myofibroblast in wound healing and fibrocontractive diseases
G Gabbiani
JOURNAL OF PATHOLOGY (2003)
End-organ dysfunction in cystic fibrosis - Association with angiotensin I converting enzyme and cytokine gene polymorphisms
PD Arkwright et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Making sense of latent TGFβ activation
JP Annes et al.
JOURNAL OF CELL SCIENCE (2003)
Decreased Smad 7 expression contributes to cardiac fibrosis in the infarcted rat heart
BQ Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Clinical implications of postsurgical adhesions
MP Diamond et al.
HUMAN REPRODUCTION UPDATE (2001)
Identification of novel TGF-β/Smad gene targets in dermal fibroblasts using a combined cDNA microarray/promoter transactivation approach
F Verrecchia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Smurf1 interacts with transforming growth factor-β type I receptor through Smad7 and induces receptor degradation
T Ebisawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGFβ receptor for degradation
P Kavsak et al.
MOLECULAR CELL (2000)
Inhibition of transforming growth factor β prevents progression of liver fibrosis and enhances hepatocyte regeneration in dimethylnitrosamine-treated rats
T Nakamura et al.
HEPATOLOGY (2000)
Fibroblast-matrix interactions in wound healing and fibrosis
B Eckes et al.
MATRIX BIOLOGY (2000)
TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis
PD Arkwright et al.
THORAX (2000)
Transcriptional control by the TGF-β/Smad signaling system
J Massagué et al.
EMBO JOURNAL (2000)
Share Paper
